Expression of concern: "Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838].
Expression of concern: "Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838].
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Publication status: expression_of_concern
A plain-language reading has not been prepared for this paper yet.